Real-world data in 2025 and beyond: Closing the strategy gap
Real-world data has already proven its power to transform patient outcomes, accelerate clinical development, and strengthen commercial strategies, but its full value is realized only when pharma organizations approach it with a cohesive, forward-looking strategy. Our white paper, Real-world data in 2025 and beyond: Closing the strategy gap, surveyed 200 life sciences executives to gather […]
The ROI of real-world data: Understanding the current and future state of RWD
From clinical trials to regulatory submissions to HEOR research, the value of real-world data (RWD) is clear. So how are today’s pharma leaders using RWD in commercialization strategies, and where are the gaps in realizing its full potential? This infographic reveals the results of Norstella’s survey of 200 life sciences executives about their use of […]